Author:
Filleron Thomas,Bonnetain Franck,Mancini Julien,Martinez Alejandra,Roché Henri,Dalenc Florence
Funder
Institut National du Cancer
Clinical Research Hospital Program from the French Ministry of Health
Subject
Pharmacology (medical),General Medicine
Reference57 articles.
1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008;Ferlay;Int J Cancer J Int Cancer,2010
2. 1st International consensus guidelines for advanced breast cancer (ABC 1);Cardoso;Breast,2012
3. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer;Miller;N Engl J Med,2007
4. Taxanes alone or in combination with anthracyclines as first-line therapy of patients with metastatic breast cancer;Piccart-Gebhart;J Clin Oncol Off J Am Soc Clin Oncol,2008
5. Gemcitabine, Epirubicin, and Paclitaxel Versus Fluorouracil, Epirubicin, and Cyclophosphamide As First-Line Chemotherapy in Metastatic Breast Cancer: A Central European Cooperative Oncology Group International, Multicenter, Prospective, Randomized Phase III Trial
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献